[1]Ñ ÍõÃÎ ÂíÃ÷.°¢¶û´Äº£Ä¬²¡ÓëÐÄÔàÀ༲²¡µÄ¹ØϵÑо¿½øÕ¹[J].×äÖÐÓëÉñ¾­¼²²¡ÔÓÖ¾,2019,26(04):493-495.[doi:10.3969/j.issn.1007-0478.2019.04.032]

µã»÷¸´ÖÆ

°¢¶û´Äº£Ä¬²¡ÓëÐÄÔàÀ༲²¡µÄ¹ØϵÑо¿½øÕ¹()

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

[1] Sassi C,Guerreiro R,Gibbs R,et al.Investigating the role of rare coding variability in Mendelian dementia genes(APP, PSEN1, PSEN2, GRN, MAPT, and PRNP)in late-onset Alzheimer's disease[J].Neurobiol Aging,2014,35(12):2881.e1-2881.e6. [2] Wimo A,Alzheimer PM.s disease international world alzheimer report 2010:the global economic impact of dementia[J].London:alzheimer's disease international[Z],2010:1-56. [3] Reitz C,Mayeux R.Alzheimer disease:epidemiology, diagnostic criteria, risk factors and biomarkers[J].Biochem Pharmacol,2014,88(4):640-651. [4] Cermakova P,Eriksdotter M,Lund LH,et al.Heart failure and Alzheimer's disease[J].J Intern Med,2015,277(4):406-425. [5] Joshi A,Jimenez E,Mendez MF.Initial heart rate reactivity to socioemotional pictures in Early-Onset alzheimer's disease[J].J Alzheimers Dis,2017,60(4):1325-1332. [6] Falsetti L,Viticchi G,Buratti L,et al.Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease:A Prospective Cohort Study[J].J Alzheimers Dis,2018,62(2):713-725. [7] Chen W,Jin F,Cao G,et al.ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease[J].Curr Drug Targets,2018,19(9):1038-1044. [8] Alosco ML,Hayes SM.Structural brain alterations in heart failure:a review of the literature and implications for risk of Alzheimer's disease[J].Heart Fail Rev,2015,20(5):561-571. [9] Qiu L,Ng G,Tan EK,et al.Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice[J].Sci Rep,2016,6(6):23964. [10] Roher AE,Debbins JP,Malek-Ahmadi M,et al.Cerebral blood flow in Alzheimer's disease[J].Vascular Health&Risk Management,2014,8(1):599-611. [11] Zamrini E,De Santi S,Tolar M.Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease[J].Neurobiol Aging,2004,25(5):685-691. [12] Vogels RL,Van Der Flier WM,Van Harten B,et al.Brain magnetic resonance imaging abnormalities in patients with heart failure[J].Eur J Heart Fail,2007,9(10):1003-1009. [13] Woo MA,Palomares JA,Macey PM,et al.Global and regional brain mean diffusivity changes in patients with heart failure[J].J Neurosci Res,2015,93(4):678-685. [14] Hampshire A. Chapter 4-A functional network perspective on the role of the frontal lobes in executive cognition[J]. Executive Functions in Health & Disease, 2017,(1):71-104. [15] Dhikav V,Duraiswamy S,Anand KS.Correlation between hippocampal volumes and medial temporal lobe atrophy in patients with Alzheimer's disease[J].Ann Indian Acad Neurol,2017,20(1):29-35. [16] Genrikhs EE,Voronkov DN,Kapkaeva MR,et al.Focal unilateral traumatic brain injury causes delayed neurodegenerative changes in the brain of rats[J].Bull Exp Biol Med,2017,164(2):211-213. [17] Peyvandi S,Chau V,Guo T,et al.Neonatal brain injury and timing of neurodevelopmental assessment in patients with congenital heart disease[J].J Am Coll Cardiol,2018,71(18):1986-1996. [18] Guo J E, Mi S B, Yan X C, et al. Effects of Gualou Xiebai Banxia decoction on blood lipid content, oxidative stress and ox-LDL/Lox-1 pathway in ApoE-/- mice[J]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2017, 42(4):752. [19] Bleckwenn M,Kleineidam L,Wagner M,et al.Impact of coronary heart disease on cognitive decline in Alzheimer's disease:a prospective longitudinal cohort study in primary care[J].Br J Gen Pract,2017,67(655):e111-e117. [20] Alosco ML,Brickman AM,Spitznagel MB,et al.The Independent association of hypertension with cognitive function among older adults with heart failure[J].J Neurol Sci,2012,323(1/2):216-220. [21] Goyal D,Macfadyen RJ,Watson RD,et al.Ambulatory blood pressure monitoring in heart failure:a systematic review[J].Eur J Heart Fail,2005,7(2):149-156. [22] Garidou ML,Diaz E,Calgari C,et al.Transcription factors May frame Aa-nat gene expression and melatonin synthesis at night in the Syrian hamster pineal gland[J].Endocrinology,2003,144(6):2461-2472. [23] Aronson MK, Ooi WL, Morgenstern H, et al. Women, myo- cardial infarction, and dementia in the very old [J].Neurology,1990,40(2):1102-1106. [24] Wozakowska-Kap¢bon B,Opolski G,Kosior D,et al.Cognitive disorders in elderly patients with permanent atrial fibrillation[J].Kardiol Pol,2009,67(5):487-493. [25] Ott A,Breteler MM,De Bruyne MC,et al.Atrial fibrillation and dementia in a population-based study. The Rotterdam Study[J].Stroke,1997,28(2):316-321. [26] Marzona I,O'donnell M,Teo K,et al.Increased risk of cognitive and functional decline in patients with atrial fibrillation:results of the ONTARGET and TRANSCEND studies[J].CMAJ,2012,184(6):E329-E336. [27] Muqtadar H,Testai FD,Gorelick PB.The dementia of cardiac disease[J].Curr Cardiol Rep,2012,14(6):732-740. [28] Justin BN,Turek M,Hakim AM.Heart disease as a risk factor for dementia[J].Clin Epidemiol,2013,5(1):135-145. [29] Jacobs V,Cutler MJ,Day JD,et al.Atrial fibrillation and dementia[J].Trends Cardiovasc Med,2015,25(1):44-51. [30] Corder EH,Ervin JF,Lockhart E,et al.Cardiovascular damage in Alzheimer disease:autopsy findings from the Bryan ADRC[J].J Biomed Biotechnol,2005(2):189-197. [31] Omar PS.Epidemiology and genetics of AlzheimerÂ's disease[J].Parkinsonism,2015,05(1):1-5. [32] Belohlavek M,Jiamsripong P,Calleja AM,et al.Patients with alzheimer disease have altered transmitral flow echocardiographic analysis of the vortex formation time[J].Journal of Ultrasound in Medicine,2009,28(11):1493-1500. [33] Wolters FJ,Bos D,Vernooij MW,et al.Aortic valve calcification and the risk of dementia:a Population-Based study[J].Journal of Alzheimers Disease,2017,55(3):893-897. [34] Deright J,Jorgensen RS,Cabral MJ.Composite cardiovascular risk scores and neuropsychological functioning:a Meta-Analytic review[J].Annals of Behavioral Medicine,2015,49(3):344-357. [35] Silajd IE,Björkqvist M,Hansson O.Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer¢fs disease[J].BMC Neurol,2015,15(1):1-5. [36] Wang YY,Zheng W,Ng CH,et al.Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease[J].Int J Geriatr Psychiatry,2017,32(1):50-57. [37] Cutando A,Montero J,Gómez-De Diego R,et al.Effect of topical application of melatonin on serum levels of C-reactive protein(CRP), interleukin-6(IL-6)and tumor necrosis factor-alpha(TNF-¦Á)in patients with type 1 or type 2 diabetes and periodontal disease[J].Journal of clinical and experimental dentistry,2015,7(5):e628-e633. [38] Liu W,Wong A,Law AC,et al.Cerebrovascular disease, amyloid plaques, and dementia[J].Stroke,2015,46(5):1402-1407. [39] Hwang SY,Kim J.An examination of the association of cognitive functioning, adherence to Sodium restriction and Na/K ratios in Korean heart failure patients[J].J Clin Nurs,2016,25(11/12):1766-1776. [40] Hanyu H,Sato T,Hirao K,et al.The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease:A longitudinal SPECT study[J].J Neurol Sci,2010,290(1/2):96-101.[12] Maruishi M,Shima T,Okada Y,et al.Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma[J].Neurol Med Chir(Tokyo),2001,41(6):300-304. [13] Anderson CS,Huang Y,Wang JG,et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial(INTERACT):a randomised pilot trial[J].Lancet Neurol,2008,7(5):391-399. [14] Mirsen T.Acute treatment of hypertensive intracerebral hemorrhage[J].Curr Treat Options Neurol,2010,12(6):504-517. [15] Anderson C,Heeley E,Heritier S,et al.Statistical analysis plan for the second INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial(INTERACT2):a large-scale investigation to solve longstanding controversy over the most appropriate management of elevated blood pressure in the[J].International Journal of Stroke,2013,8(5):327-328. [16] Morgenstern LB,Hemphill JC,Anderson C,et al.Guidelines for the management of spontaneous intracerebral hemorrhage[J].Chinese Journal of Cerebrovascular Diseases,2015,46(7):2032-2060. [17] Qureshi AI,Palesch YY,Barsan WG,et al.Intensive Blood-Pressure lowering in patients with acute cerebral hemorrhage[J].N Engl J Med,2016,375(11):1033-1043. [18] Chung PW,Kim JT,Sanossian N,et al.Association between hyperacute stage blood pressure variability and outcome in patients with spontaneous intracerebral hemorrhage[J].Stroke,2018,49(2):348-354. [19] Rabinstein AA.Optimal blood pressure after intracerebral hemorrhage:still a moving target[J].Stroke,2018,49(2):275-276. [20] Hilkens NA,Algra A,Greving JP.Prediction models for intracranial hemorrhage or major bleeding in patients on antiplatelet therapy:A systematic review and external validation study[J].Journal of Thrombosis and Haemostasis,2015,14(1):167-174. [21] Collyer TC,Gray DJ,Sandhu R,et al.Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography(R)Platelet MappingTM[J].Br J Anaesth,2009,102(4):492-498. [22] Baharoglu MI,Cordonnier C,Salman RA,et al.Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy(PATCH):a randomised, open-label, phase 3 trial[J].Lancet,2016,387(138):2605-2613. [23] Kottapally M,Kuramatsu JB.Kuramatsu JB, et al. anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA(10)[J].Am J Respir Crit Care Med,2016,193(2):211-212. [24] Vanderwerf J D, Kumar M A. Management of neurologic complications of coagulopathies[J]. Handbook of Clinical Neurology, 2017, 141:743-764. [25] Al-Shahi Salman R, Law ZK, Bath PM, et al.Haemostatic therapies for acute spontaneous intracerebral haemorrhage[J].Cochrane Database Syst Rev,1994,4(5951):51-52. [26] Lim-Hing K,Rincon F.Secondary hematoma expansion and perihemorrhagic edema after intracerebral hemorrhage:from bench work to practical aspects[J].Front Neurol,2017,8(74):1-12. [27] Cusack TJ,Carhuapoma JR,Ziai WC.Update on the treatment of spontaneous intraparenchymal hemorrhage:medical and interventional management[J].Curr Treat Options Neurol,2018,20(1):1-22.